Loading...
XKRX
118000
Market cap15mUSD
Jul 10, Last price  
1,251.00KRW
1D
-9.94%
1Q
460.99%
Jan 2017
-88.52%
IPO
-82.05%
Name

The MediPharm Co Ltd

Chart & Performance

D1W1MN
XKRX:118000 chart
P/E
43.13
P/S
0.65
EPS
29.01
Div Yield, %
—
Shrs. gr., 5y
28.99%
Rev. gr., 5y
4.06%
Revenues
32.82b
+62.42%
3,427,010,00029,404,109,00034,386,311,97022,314,787,65012,465,767,03011,762,225,96011,450,627,55011,232,856,46036,880,327,35034,471,966,03056,155,488,90026,895,986,46018,613,345,00019,098,327,00017,256,902,00020,208,078,00032,822,071,000
Net income
498m
-94.63%
343,970,000-2,738,016,000-12,527,851,250-6,406,158,930-4,562,578,000-8,846,494,000-7,593,662,000-8,620,667,000-2,908,727,000-12,042,294,450-4,042,868,66011,252,452,7607,739,923,000-49,554,716,000-14,540,250,0009,276,601,000498,242,840
CFO
2.42b
-45.95%
-292,680,0001,288,185,0001,267,776,7101,493,406,930258,121,110-5,221,728,080-3,558,414,880-4,851,448,730-12,687,553,540-2,708,019,6201,244,910,3803,794,996,000-1,491,581,000-2,529,060,000-12,857,231,0004,477,135,0002,419,706,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Headquartered in Seoul, South Korea, Wooridul Huebrain Limited was founded in 2009. The company's operations span the medical, life and health, pharmaceutical, and storage industries. Its offerings include a range of medical equipment and devices, health-related apparatus, pharmaceutical products, and computer server solutions. The firm rebranded as Wooridul Huebrain Limited in April 2014, having previously operated under the name Wooridul Life Sciences Limited.
URL
http://www.chorokbaemhc.com/
IPO date
Dec 30, 2009
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT